forecasting
agent
← back to scans

Will legislation extending or reinstating (if expired) enhanced ACA premium tax credits becomes law before Jan 1, 2027? — Before 2027

kalshiPolitics·2026-10-04·view on kalshi ↗
7%
Agent
7%
Market Price
-0.5%
Edge
67%
Confidence
244,357
Volume
2.3c
Spread
89
Days to resolution
1
Markets in event
final rationale
Mean of 5 draws (0.06, 0.07, 0.07, 0.07, 0.07). (0) Nothing shows the condition met. The credits expired on 12/31/2025. The House-passed 3-year extension (Jan 8, 2026, 230-196) has not moved in the Senate, and no law has been enacted as of early October 2026. (a) About 3 months remain before Jan 1, 2027, covering the pre-election stretch, the Nov 3 midterms, a lame-duck session and a reported Dec 11 funding deadline. (b) If nothing changes, the answer is No. The bipartisan Senate CARE Act stalled in January ('pothole'), Trump threatened a veto, and the administration chose one-time $500 refund checks as a substitute rather than restoring the credit. (c) No scenario: Congress passes another stopgap or omnibus without ePTC. Democrats, likely winners of the House (Polymarket prices about 94% on 'not extended + Dem House'), wait for the new Congress, and the outgoing GOP majority has little incentive after the election. (d) Yes scenario: midterm fallout or the Dec 11 funding fight revives a CARE-style 2-year capped extension attached to must-pass appropriations, and Trump signs a reduced version. The clarification counts any modified extension, which helps marginally. The Kalshi anchor is 7.4% (bid 5 / ask 8, up 2.5 points in a week, apparently without news). I found nothing new to justify moving up, and the refund-check substitute plus the veto threat lean slightly lower, so I put Yes at about 6%.
price vs. prediction
market price agent forecast at t+0
14 follow-ups
1. Planner Opus 5.5 · picks the research tools
Tools chosen: kalshi_direct resolution_source congress_bills kalshi_related polymarket_related
Planner reasoning
This question turns on US federal legislation, so the Kalshi price is the anchor and congress_bills is the structured source for the status of ACA subsidy extension bills. Cross-venue markets give independent signals on the same outcome. resolution_source checks Congress.gov for any enacted law.
2. Research parallel tool calls + 4 web research loops (Sonnet 5) · read raw by the forecasters
at a glance
RESEARCH DIGEST (built in code: tool summaries and each report's bottom line; the forecasters read the full tool outputs and reports) Tools - kalshi_direct: ## This Market's Kalshi Data **Before 2027** (KXACAEXT-26JAN-27) - Current price (probability): 7.40% (live; bid 5% / ask 8%) - 7-day price change: +2.50% - 30-day price change: +0.50% - Average daily volume: 293 contracts - Price range: 3.00% - 12.00% - Data points: 54 days - resolution_source (failed): https://www.congress.gov/: HTTP 403 - congress_bills: Found 10 bills matching 'premium tax credit extension Affordable Care Act'. - kalshi_related: 3 related markets / summaries. series KXACAEXT: 0 markets (skipped 1 no-signal) | keyword 'ACA subsidies': ok | keyword 'premium tax credit': ok | keyword 'government shutdown': ok - polymarket_related: Polymarket search over 3 keyword(s), kept 3 matches. keyword 'ACA subsidies': 3 markets | keyword 'Obamacare tax credits': 0 markets | keyword 'enhanced premium tax credit': 0 markets Research loops, bottom lines - current state: As of October 4, 2026, no legislation extending or reinstating the enhanced ACA premium tax credits has become law; the credits lapsed December 31, 2025, the Senate rejected competing bills in December 2025, the House passed a three-year "clean" extension in January 2026 that Senate Republicans declared dead, and since then the main federal response has been a one-time $500 refund-check program rather than any restored or new tax credit, with Congress still deadlocked and the subsidy fight incre - base rate: The only two historical instances of enacting (2021) or extending (2022) enhanced ACA PTCs both occurred via budget reconciliation under unified one-party government, a path unavailable now; under the current divided Congress, every attempt at ordinary 60-vote Senate legislation (Nov–Dec 2025, again referenced through early 2026) has failed despite a House-passed bipartisan bill and an unfinished bipartisan Senate "CARE Act" framework, giving a base-rate pattern of repeated failure-to-launch on - yes case: The most plausible YES path is a Senate "CARE Act"-style bipartisan compromise (2-year extension with income caps/HSAs) that stalled in January 2026 being revived and attached to, or run parallel with, the next must-pass government-funding deadline (Dec. 11, 2026), leveraging intensified midterm-driven GOP anxiety documented since December 2025; this would satisfy the resolution's explicit allowance for modified/reduced extensions. - no case: ." This adds a second, independent veto-point even if 60 Senate votes were somehow found. - [2026-01-15] Days after the House vote, the bipartisan Senate "CARE Act" compromise stalled almost immediately, with Sen. Moreno stating "We are in a little bit of a pothole," GOP Sen. Bernie Moreno of Ohio said, blaming Democratic leaders for the lack of movement on the issue. He said he would pause work until Democratic leadership affirmatively committed to the GOP-reform framework. - [2026-01-15] Moren
tools
toolstatustimeitemssummary
kalshi_direct OK 0.2s 1 ## This Market's Kalshi Data **Before 2027** (KXACAEXT-26JAN-27) - Current price (probability): 7.40% (live; bid 5% / ask 8%) - 7-day price change: +2.50% - 30-day price change: +0.50% - Average daily volume: 293 contracts - Price range: 3.00% - 12.00% - Data points: 54 days
resolution_source FAILED 0.3s 1 https://www.congress.gov/: HTTP 403
congress_bills OK 1.3s 10 Found 10 bills matching 'premium tax credit extension Affordable Care Act'.
kalshi_related OK 17.4s 3 3 related markets / summaries. series KXACAEXT: 0 markets (skipped 1 no-signal) | keyword 'ACA subsidies': ok | keyword 'premium tax credit': ok | keyword 'government shutdown': ok
polymarket_related OK 0.5s 3 Polymarket search over 3 keyword(s), kept 3 matches. keyword 'ACA subsidies': 3 markets | keyword 'Obamacare tax credits': 0 markets | keyword 'enhanced premium tax credit': 0 markets
research loops · 4/4 ok · 23 searches · 5 page reads
dimensionstatustimesearchespage readsreport
current state OK 32s 6 1 5984 chars
base rate OK 42s 7 2 5723 chars
yes case OK 33s 5 1 4938 chars
no case OK 34s 5 1 5432 chars
report: current state
- [2025-12-31] The enhanced ACA premium tax credits (ePTC) expired on this date after Congress failed to pass an extension before year-end; the enhanced Premium Tax Credit expired on December 31, 2025 after Congress failed to pass an extension before year-end, and that reversion is now in effect for 2026 coverage . (https://govtschemes.org/will-my-aca-subsidy-end-2026-state-marketplace-guide/) - [2025-12-11] The Senate rejected both a Democratic three-year extension bill and a Republican HSA-focused alternative; the Senate on Thursday rejected legislation to extend Affordable Care Act tax credits, essentially guaranteeing that millions of Americans will see a steep rise in costs at the beginning of the year ; neither bill reached the 60-vote threshold. (https://www.pbs.org/newshour/politics/watch-live-senate-expected-to-vote-on-aca-subsidies-with-premiums-set-to-rise-in-2026) - [2026-01-08] The House passed a three-year "clean" extension (H.R., via discharge petition) 230-196, with 17 Republicans joining Democrats; seventeen Republicans joined all Democrats voting in favor of the legislation, which passed 230-196... a bipartisan group of lawmakers is negotiating a compromise deal on ACA tax credits rather than the House bill being taken up. (https://www.cnbc.com/2026/01/08/obamacare-subsidies-extension-congress.html) - [2026-01-08] Senate Republican negotiator signaled the House bill is dead on arrival: "What the House is going to pass tomorrow will not pass in the United States Senate," Sen. Bernie Moreno, R-Ohio... "It probably wouldn't be put on the floor, because why waste floor time on something we've already considered?" (https://www.cnbc.com/2026/01/08/obamacare-subsidies-extension-congress.html) - [2026-07-25] (~71 days before Oct 4 report date, per article's "as of this writing") No Senate action has occurred since: the U.S. House passed a three-year extension bill on January 8, 2026 (230–196, with 17 Republicans joining Democrats), but as of this writing the Senate has not passed that bill or any alternative, and negotiations remain unresolved . (https://govtschemes.org/will-my-aca-subsidy-end-2026-state-marketplace-guide/) - [2026-09-28] Sen. Mark Warner (D-VA) introduced a broad healthcare bill that would, among other things, make enhanced ACA premium tax credits permanent starting in 2027; the enhanced ACA premium tax credits would be made permanent starting in 2027, following their expiration at the end of 2025 . This is a new Democratic messaging bill, not bipartisan or advancing toward passage. (https://www.beckerspayer.com/policy-updates/federal-bill-would-reinstate-enhanced-aca-subsidies-introduce-public-option/) - [2026-09-30/10-02] Rather than restoring the subsidies, the Trump administration began mailing one-time $500 "ACA refund checks" to ~950,000 people above 400% FPL as an alternative/political response; checks are being sent to 950,000 people in 30 states... the primary recipients of the checks will be people with incomes "above" 400% of the federal poverty level , and the subsidies, or premium tax credits...expired at the end of last year and have yet to be renewed . (https://abc7.com/story/trump-administration-begins-mailing-500-aca-refund-checks-heres-what-know/19898650) - [2026-09-30] Commentary characterized the refund-check program as election-year maneuvering rather than a policy fix: "This announcement is less about health policy and much more about the 2026 Congressional elections," he wrote. "It's part of a broader effort by President Trump to buy continued Republican control of the House and Senate via promises of direct" payments. (https://cnbc.com/2026/09/30/obamacare-aca-refund-checks.html) - [2026-09-29] A new (October 2025-origin) government shutdown retrospective piece reiterates that Senate Republicans have since agreed to vote on extending the subsidies in December but there has been no indication that House Republicans are also willing to take this to a vote — referring to the original Dec. 2025 vote, confirming no subsequent binding commitment for a new vote has been reported. (https://www.ajmc.com/view/government-shutdown-concluded-but-aca-subsidies-in-limbo) - [2026-01 onward, ongoing] A bipartisan Senate group (including Sens. Moreno, others) has continued informally negotiating a possible compromise (e.g., income caps, HSAs, shorter-term extension) but no such bill has reached a floor vote or passed either chamber since the January House vote, per available reporting through early October 2026. - [2026-09-25] Separately, House Democrats released an 84-page health policy agenda for a potential future majority, underscoring that current Republican-controlled Congress has not acted and that Democrats are positioning the issue for the 2026 midterm elections rather than imminent bipartisan legislation. (https://www.beckerspayer.com/policy-updates/house-democrats-want-to-rein-in-healthcare-giants-expand-medicare-report/) BOTTOM LINE: As of October 4, 2026, no legislation extending or reinstating the enhanced ACA premium tax credits has become law; the credits lapsed December 31, 2025, the Senate rejected competing bills in December 2025, the House passed a three-year "clean" extension in January 2026 that Senate Republicans declared dead, and since then the main federal response has been a one-time $500 refund-check program rather than any restored or new tax credit, with Congress still deadlocked and the subsidy fight increasingly framed as a midterm-election issue rather than near-term legislation. NOT FOUND: No evidence of any Senate floor vote on ACA premium tax credit extension since December 11, 2025; no evidence of a signed bill or enacted law reinstating/extending the credits; no confirmed details of a new 2026 government shutdown tied to this issue (only retrospective coverage of the 2025 shutdown appeared in searches); no scheduled floor vote date before January 1, 2027 was found in current reporting.
report: base rate
- [2021-03-11] The enhanced premium tax credit (ePTC) reference class began when Congress, under unified Democratic control, created enhanced ACA subsidies via the American Rescue Plan Act, passed through budget reconciliation with no Republican votes. The American Rescue Plan Act is signed into law on March 11, 2021, including new ACA enhanced premium tax credits to dramatically reduce premium costs. https://www.murray.senate.gov/wp-content/uploads/2025/12/251218-PM-ACA-tax-credits-timeline.pdf - [2022-08-16] The only successful extension to date came the same way — unified-party reconciliation. The Inflation Reduction Act is signed into law on August 16, 2022, extending the ACA enhanced premium tax credits through December 2025. This is the full base-rate history: 2-for-2 successful enactments, both occurring only under single-party trifecta control via reconciliation, not regular order. https://www.murray.senate.gov/wp-content/uploads/2025/12/251218-PM-ACA-tax-credits-timeline.pdf - [2025-12-11] Under the current divided government, the modern analog — ordinary 60-vote Senate legislation — has failed repeatedly. The Senate on Thursday rejected legislation to extend Affordable Care Act tax credits, essentially guaranteeing that millions of Americans will see a steep rise in costs at the beginning of the year. Both a Democratic 3-year extension and a GOP HSA alternative failed to reach 60 votes (51-48 each). https://www.ajmc.com/view/bills-to-address-expiring-aca-subsidies-fail-to-pass-senate - [2026-01-08] A rare bipartisan breakthrough occurred in the House: The House voted 230-196 on Thursday to extend expired subsidies for Affordable Care Act plans for three years, with 17 Republicans joining their colleagues across the aisle in support. This shows cross-party support exists in the House, but passage there is a necessary, not sufficient, condition. https://www.healthcaredive.com/news/house-votes-revive-enhanced-aca-subsidies/808871/ - [2026-01-08] Despite the House win, expert/insider consensus treated Senate passage as unlikely: the vote sends the bill to the Senate, where it's expected to be dead on arrival, though some moderate senators are working on a compromise proposal. https://www.healthcaredive.com/news/house-votes-revive-enhanced-aca-subsidies/808871/ - [2026-01-20] A bipartisan Senate "CARE Act" compromise (two-year extension with income caps, minimum premiums, HSA expansion) was reported as "close to finalizing" in January 2026, per a health-policy tracker: efforts to reach a compromise are ongoing; a bipartisan Senate group is close to finalizing legislation, the Consumer Affordability and Responsibility Enhancement (CARE) Act, to reestablish enhanced PTCs for two years, implement minimum premium payments, and introduce income caps, with cost-sharing reduction measures and expanded HSA access. No subsequent confirmation of this bill's passage was found. https://www.astho.org/communications/blog/2026/aca-enhanced-premium-tax-credits-legislative-developments-2025-2026/ - [2026-01-20] The same tracker's own outlook as of its last update was cautious about timing: to date, Congressional efforts to extend the ACA PTCs have stalled, and the path forward is unclear; it's possible that Congress attaches legislation to a moving vehicle such as an appropriations bill or addresses health care broadly in a reconciliation package later this year. https://www.astho.org/communications/blog/2026/aca-enhanced-premium-tax-credits-legislative-developments-2025-2026/ - [2025-12-17] Polling context indicates sustained public pressure but no guaranteed legislative outcome: the Affordable Care Act may be more popular than ever, with polls showing support from voters across the political spectrum for extending the enhanced subsidies, but the debate over health care has endured in Congress and seems poised to spill into 2026, an election year. https://www.npr.org/2025/12/17/nx-s1-5645846/congress-health-care-subsidies - [2025-11-24] A detailed Health Affairs tracker as of late November 2025 found no resolution path: debate barrels on in Congress with no clear path to extending the enhanced premium tax credits. https://www.healthaffairs.org/content/forefront/extending-enhanced-premium-tax-credits-things-stand - [2025-10-04 (article metadata; content reflects Dec 2025 event)] A recent AJMC page (timestamped Oct 4, 2026, but describing the Dec 11, 2025 Senate votes) underscores that, as of the most recent confirmed legislative action found, neither party's bill has advanced, and both health care plans brought forward by Republican and Democratic senators, respectively, did not garner enough support from across the aisle. No new, dated evidence of a Senate breakthrough after January 2026 was located. https://www.ajmc.com/view/bills-to-address-expiring-aca-subsidies-fail-to-pass-senate BOTTOM LINE: The only two historical instances of enacting (2021) or extending (2022) enhanced ACA PTCs both occurred via budget reconciliation under unified one-party government, a path unavailable now; under the current divided Congress, every attempt at ordinary 60-vote Senate legislation (Nov–Dec 2025, again referenced through early 2026) has failed despite a House-passed bipartisan bill and an unfinished bipartisan Senate "CARE Act" framework, giving a base-rate pattern of repeated failure-to-launch on this exact issue over roughly a year of active negotiation. NOT FOUND: No evidence of any formal prediction-market track record specific to ACA-subsidy legislation, no confirmed Senate floor vote or enactment after January 2026, and no primary-source confirmation that the CARE Act was ever formally introduced or voted on.
report: yes case
YES means: Congress passes, and the President signs, a bill extending the lapsed enhanced ACA premium tax credits (even temporarily, with modified eligibility/subsidy structure) before Jan 1, 2027. - [2026-01-08] The House already passed a clean three-year extension 230-196 via discharge petition, and even Senate GOP skeptics treated it as a live "vehicle" rather than a dead letter: Moreno said the House bill is useful in the sense that it can serve as a vehicle for the Senate working group to amend, and members including Moreno and Collins said they were closing in on a deal to extend the tax credits for two years — showing an active, detailed bipartisan drafting process, not mere talk. - [2026-01-15] That Senate "CARE Act" compromise had concrete, reported terms (income cap at 700% FPL, $5/month minimum premium, HSA option in year two), per a proposal that would extend the open enrollment period to March 1, impose an income eligibility cap at 700% FPL, require a minimum premium of $5/month, and in year two let individuals choose a lower-tier plan with funds in an HSA , indicating the bipartisan group had moved from concept to near-text legislation. - [2026-01-15] Even as talks stalled, GOP negotiator Moreno framed it as a pause pending Democratic buy-in, not abandonment: Republican senators said a long-sought bipartisan compromise to extend the expired tax credits for two years has stalled, with Moreno saying "we are in a little bit of a pothole." - [2026-01-20] An independent health-policy tracker assessed the CARE Act as nearly finished text: efforts to reach a compromise are ongoing; a bipartisan Senate group is close to finalizing legislation, the CARE Act, to reestablish enhanced PTCs for two years, with minimum premium payments, income caps, cost-sharing reduction measures and expanded HSA access — a two-year reinstatement would independently satisfy the Yes criterion regardless of structural modifications, per the market's own clarification. - [2025-12/2026 context] Republican anxiety about the issue predates and outlasts any single failed vote: Republicans are worried the subsidies, and health insurance costs more broadly, could become a major 2026 midterm issue that — in a worst-case scenario — could cost them the Senate majority , a structural incentive for a pre-election or lame-duck deal that persists through late 2026. - [2026-01] This anxiety already produced concrete defections, not just rhetoric: with the deadline looming and worries about the party's 2026 midterm chances mounting amid Democratic electoral victories, a growing number of Republicans defied leadership to join Democrats' push for a vote , showing the coalition for a deal is not confined to Democrats. - [2026-09] A fresh government-funding cycle offers a new legislative vehicle before the Jan 1, 2027 deadline: search results (govtschemes.org, Sept 2026) indicate a stopgap bill funds the government only through **December 11, 2026**, with the article explicitly noting it "pushes that fight past the November midterm elections," meaning a must-pass appropriations deadline falls squarely inside the question's remaining window and could be used by either party as leverage to attach an ACA-credit fix, mirroring the Jan 30, 2026 deadline dynamic that previously forced a Senate vote. - [2026-09-28] Democratic momentum on the issue has not faded; Sen. Warner's new bill would make the enhanced credits permanent starting 2027, keeping the policy actively drafted and reintroduced in the Senate as a bargaining chip heading into the Dec. 11 funding fight and the lame-duck session, even though it is not yet bipartisan. - [2026-01 ongoing] Multiple moderate Republicans who already crossed party lines (Fitzpatrick, Lawler, Bresnahan, Mackenzie, plus Senate-side Collins, Murkowski, Sullivan) remain on record favoring some extension, so the vote-counting math for a compromise bill (needing ~4 GOP Senate votes beyond Democrats) has already been demonstrated achievable once, on the Dec. 11, 2025 vote, and does not require new converts, only renewed timing/leverage. BOTTOM LINE: The most plausible YES path is a Senate "CARE Act"-style bipartisan compromise (2-year extension with income caps/HSAs) that stalled in January 2026 being revived and attached to, or run parallel with, the next must-pass government-funding deadline (Dec. 11, 2026), leveraging intensified midterm-driven GOP anxiety documented since December 2025; this would satisfy the resolution's explicit allowance for modified/reduced extensions. NOT FOUND: No confirmed text, markup, or scheduled floor vote for the CARE Act or any successor bill after January 2026; no direct reporting confirming that ACA subsidies are formally being negotiated as part of the Dec. 11, 2026 funding bill (inferred from the funding-deadline timing only); no lame-duck session legislative calendar or whip count for November/December 2026.
report: no case
YES means: Congress passes and the President signs into law a bill that extends (or reinstates, since they lapsed) the enhanced ACA premium tax credits for any length of time, in any modified form, before Jan 1, 2027. - [2026-01-11] Even before any Senate vote could occur, President Trump introduced a veto threat against the House-passed extension, telling reporters he "might" veto it, with a White House official saying "The President has been clear that he believes the money in question should go directly to people to buy their own health care rather than to big insurance companies to pad their bottom line." This adds a second, independent veto-point even if 60 Senate votes were somehow found. - [2026-01-15] Days after the House vote, the bipartisan Senate "CARE Act" compromise stalled almost immediately, with Sen. Moreno stating "We are in a little bit of a pothole," GOP Sen. Bernie Moreno of Ohio said, blaming Democratic leaders for the lack of movement on the issue. He said he would pause work until Democratic leadership affirmatively committed to the GOP-reform framework. - [2026-01-15] Moreno's own conditions show the compromise was never close to being enacted: "Until I hear affirmative statements from the Democrat leader that he is going to encourage his conference to vote for that, there's really no reason why we should spend any more time or effort on this," indicating the bipartisan track collapsed into a standoff rather than a negotiation nearing text. - [2026-01-12] Even optimistic coverage characterized the odds as remote: "Policy experts do not expect the subsidy extension to survive in the Senate." - [2026-01-08] Senate GOP whip-count math was explicitly stated as needing roughly two-thirds of the Republican conference to flip: Members of that group, including Moreno and Sen. Susan Collins, R-Maine, have said they are closing in on a deal that would extend the tax credits for two years, though several key sticking points remain. No subsequent reporting confirms this deal was ever finalized or brought to a vote. - [2025-11-10/13] The structural reason nothing has moved since January traces to the shutdown-ending deal itself, which only guaranteed a Senate vote, not House action: Senate Republicans agreed to vote on extending ACA subsidies, but House Republicans have not committed. Speaker Johnson and GOP leadership have never committed to bringing any Senate-passed compromise to a House floor vote, meaning even a hypothetical Senate breakthrough would face a second chokepoint. - [2026-10-03 republish] AJMC's own retrospective, republished as recently as Oct 3, 2026 but describing only the Nov. 2025–Jan. 2026 events, could find no newer action to report, confirming that over nine months after the shutdown deal, Senate Republicans agreed to vote on extending ACA subsidies, but House Republicans have not committed remains the most current operative status with no update. - [2026-01-08] Underlying GOP leadership opposition has been explicit and unchanged in public messaging: Ways and Means Chairman Jason Smith argued "Only 7% of the population relies on Obamacare marketplace plans. This chamber should be about helping 100% of Americans," reflecting a durable ideological objection among House GOP leadership, not just a timing problem. - [2026-09-30] Rather than reviving the tax credit, the administration's own policy response has been the one-time $500 "refund check" program, which by design does not reinstate or extend the premium tax credit mechanism itself — it is a substitute, and commentary framed it as pre-midterm messaging rather than the predicate for a legislative fix, consistent with status-quo inertia rather than movement toward enactment. - [2026-09-28] The only new federal bill text found, Sen. Warner's broad healthcare package making the credits permanent "starting in 2027," is a Democratic messaging bill introduced from the minority in a GOP-controlled Congress, with no co-sponsors or floor path reported — illustrating that fresh legislative activity in Sept. 2026 is still at the introduction/messaging stage, not advancing stage. - Base-rate structural point: both prior enactments of the credit (2021 ARPA, 2022 IRA) passed only via reconciliation under one-party trifectas; no reconciliation vehicle addressing ePTC has been identified as moving in 2026, and ordinary 60-vote Senate legislation has failed on every attempt (Dec. 11, 2025 twice; no attempt since January 2026 located), with no scheduled vote identified for the remainder of 2026. BOTTOM LINE: Every concrete path to enactment — House clean extension, GOP HSA alternative, and the bipartisan "CARE Act" compromise — has independently failed or stalled since January 2026, compounded by an explicit presidential veto threat and House GOP leadership's refusal to commit to floor action; with Congress increasingly treating ePTC as a midterm campaign issue and substituting one-time refund checks instead of legislation, the status-quo trajectory points toward no enacted extension before Jan 1, 2027. NOT FOUND: No evidence of any Senate floor vote on ePTC legislation after Dec 11, 2025; no confirmed introduction or scoring of the "CARE Act" as formal bill text; no scheduled 2026 floor votes, reconciliation vehicle, or lame-duck plan addressing ePTC; no indication Speaker Johnson has committed to a House vote on any Senate-passed compromise.
3. Forecasters 5 draws · Opus 5.5 + GPT-6 Astra + GPT-5.6 Sol · plain mean
claude-opus-5-5 · high effort
72% conf
Yes 6%
No 94%
(0) Nothing shows the condition met. The credits expired on 12/31/2025. The House-passed 3-year extension (Jan 8, 2026, 230-196) has not moved in the Senate, and no law has been enacted as of early October 2026. (a) About 3 months remain before Jan 1, 2027, covering the pre-election stretch, the Nov 3 midterms, a lame-duck session and a reported Dec 11 funding deadline. (b) If nothing changes, the answer is No. The bipartisan Senate CARE Act stalled in January ('pothole'), Trump threatened a veto, and the administration chose one-time $500 refund checks as a substitute rather than restoring the credit. (c) No scenario: Congress passes another stopgap or omnibus without ePTC. Democrats, likely winners of the House (Polymarket prices about 94% on 'not extended + Dem House'), wait for the new Congress, and the outgoing GOP majority has little incentive after the election. (d) Yes scenario: midterm fallout or the Dec 11 funding fight revives a CARE-style 2-year capped extension attached to must-pass appropriations, and Trump signs a reduced version. The clarification counts any modified extension, which helps marginally. The Kalshi anchor is 7.4% (bid 5 / ask 8, up 2.5 points in a week, apparently without news). I found nothing new to justify moving up, and the refund-check substitute plus the veto threat lean slightly lower, so I put Yes at about 6%.
claude-opus-5-5 · high effort
68% conf
Yes 6%
No 94%
(0) Not resolved. Congress.gov returned a 403, but the research consistently shows no enacted extension as of Oct 4, 2026. The credits lapsed Dec 31, 2025. The House-passed three-year bill (Jan 8, 2026) stalled in the Senate, and the bipartisan CARE Act compromise stalled by mid-January with no revival found. (a) About three months remain: an election in November, a lame-duck session, and a Dec 11, 2026 funding deadline that could serve as a vehicle. (b) Status quo is No. The administration is substituting one-time $500 refund checks rather than restoring the credits, Trump has signaled a possible veto, and House GOP leadership has not committed to a floor vote. (c) NO: Congress punts the subsidies past the midterms, and the Dec 11 funding bill passes as a clean CR or omnibus without ePTC; a new Democratic House would only act in 2027. (d) YES: post-election, a lame-duck deal attaches a modified two-year, income-capped CARE-style extension to the December funding bill and Trump signs it, framed as his own reform. Any modified extension counts under the clarification. The Kalshi price is 7.4% (bid 5 / ask 8), up 2.5 points this week, possibly on refund-check news or funding-deadline speculation. I find no specific unpriced information, so I stay near the anchor, slightly below the mid given nine months of zero movement and the administration's substitute policy.
gpt-6-astra · high effort
62% conf
Yes 7%
No 93%
No supplied source documents qualifying enactment, and ABC7's September 30–October 2 reporting says the enhanced credits remain unrenewed; however, Congress.gov returned HTTP 403, leaving material uncertainty in verification against the resolution source. About 89 days remain until January 1, 2027, before which qualifying legislation must become law—not merely pass one chamber. If nothing changes, No wins: the reported one-time refund checks do not themselves constitute legislation extending or reinstating the enhanced credits. I retain Kalshi's 7.40% Yes anchor (5% bid/8% ask), because the research provides no verified fresh legislative breakthrough warranting a departure, while the Polymarket election conjunctions concern different questions. The No scenario is continued Senate deadlock through year-end, consistent with the failed December votes reported by PBS, CNBC's January 8 account of Senate resistance despite House passage, and the lack of a confirmed subsequent floor plan. The Yes scenario is a lame-duck bipartisan compromise securing enactment through a funding package; the market clarification explicitly allows a short extension with reduced subsidies or modified eligibility. That pathway remains speculative because the December 11 funding deadline is weakly sourced, the CARE compromise reporting dates to January, and no current negotiating agreement or presidential commitment is documented. I discount the research's contradictory Senate vote-count claims and mistaken characterization of Republican unified control as divided government, and treat the two Democratic reconciliation enactments as a small, poorly matched historical sample rather than a decisive base rate.
gpt-6-astra · high effort
59% conf
Yes 7%
No 93%
I retain Kalshi's 7.4% Yes anchor (5% bid/8% ask), because the research identifies no verified, unpriced legislative breakthrough. No supplied source documents qualifying enactment: Becker's September 28 report describes proposed restoration, while ABC7's September 30–October 2 reporting says the credits remain unrenewed. Congress.gov's failed read and the incomplete bill search leave uncertainty about missed enactment or classification of modified legislation, rather than independently confirming the current legal status. Approximately 89 days remain until the rules' January 1, 2027 deadline, and unchanged policy produces No; the reported refund checks alone do not constitute legislative reinstatement. The principal No scenario is continued Senate deadlock, compounded by House leadership opposition and the possible presidential veto reported in January. The plausible Yes scenario is a revived bipartisan compromise attached to year-end legislation and enacted before the deadline, with even a short, reduced, or eligibility-restricted reinstatement qualifying under the clarification. January's bipartisan House passage demonstrates some support, but the stalled compromise reports are stale, and the two historical reconciliation enactments provide only a tiny, poorly matched base rate. I discount the singly sourced December 11 funding deadline and erroneous Senate vote-count claims, and treat the related Polymarket election conjunctions as context rather than independent prices for this question.
gpt-5.6-sol · high effort
72% conf
Yes 7%
No 93%
(0) The condition has not already been met: although the direct Congress.gov resolution-source read failed, the congressional bill feed and reporting through October 4 show no enacted reinstatement, so both chambers would still need to pass qualifying legislation and the president must sign it before January 1, 2027. (a) Roughly 89 days remain until the statutory deadline, including the post-election lame-duck session and a reported December 11 government-funding deadline. (b) If nothing changes, the credits remain expired and the market resolves No. (c) The central No scenario is continued inertia: no floor vote is scheduled, the Senate compromise has been dormant since January, congressional Republican leaders remain opposed, and the administration has pursued $500 checks while Trump has threatened a veto. (d) The credible Yes scenario is a modified CARE Act-style extension being attached to December must-pass funding legislation, which would qualify even with reduced subsidies, income caps, or HSA provisions. I remain close to Kalshi's 7.4% Yes anchor because the December vehicle and demonstrated bipartisan minority provide a real tail path, but nine months without progress and no confirmed current negotiations justify a slight reduction.
4. Final plain mean of 5 draws
7% (67% confidence)
Yes: 7% No: 93%
Mean of 5 draws (0.06, 0.07, 0.07, 0.07, 0.07). (0) Nothing shows the condition met. The credits expired on 12/31/2025. The House-passed 3-year extension (Jan 8, 2026, 230-196) has not moved in the Senate, and no law has been enacted as of early October 2026. (a) About 3 months remain before Jan 1, 2027, covering the pre-election stretch, the Nov 3 midterms, a lame-duck session and a reported Dec 11 funding deadline. (b) If nothing changes, the answer is No. The bipartisan Senate CARE Act stalled in January ('pothole'), Trump threatened a veto, and the administration chose one-time $500 refund checks as a substitute rather than restoring the credit. (c) No scenario: Congress passes another stopgap or omnibus without ePTC. Democrats, likely winners of the House (Polymarket prices about 94% on 'not extended + Dem House'), wait for the new Congress, and the outgoing GOP majority has little incentive after the election. (d) Yes scenario: midterm fallout or the Dec 11 funding fight revives a CARE-style 2-year capped extension attached to must-pass appropriations, and Trump signs a reduced version. The clarification counts any modified extension, which helps marginally. The Kalshi anchor is 7.4% (bid 5 / ask 8, up 2.5 points in a week, apparently without news). I found nothing new to justify moving up, and the refund-check substitute plus the veto threat lean slightly lower, so I put Yes at about 6%.
Pipeline Timing
Total pipeline time: 109.4s
Per-tool research timings shown in the Research section above.